Daniel Ruppar - Analyst Profile
Research Director - Connected Health
Frost & Sullivan
•15 years of Healthcare market expertise. Particular expertise in:
-Market Analysis, Modeling and Forecasting
-Qualitative & Quantitative Research
-Technical Evaluation, Opportunity Identification
-Manages Frost & Sullivan’s Connected Health global research program.
-Project management experience in Health IT, Telehealth, Remote Patient Monitoring, Imaging Markets
-Project and analysis experience in multiple areas of Pharma/Biotech including cardiovascular diseases, diabetes, drug delivery, contract research, contract manufacturing, oncology and specialty pharmaceuticals
-Consulting duties for Pharmaceutical, Med Tech, Venture Capital and Financial Services clients
What I bring to the Team
•Both Analyst and Industry background – Multiple therapy areas, healthcare market verticals, and outsourcing markets
•Project management, strategic planning experience
•Business development and client management experience
•Presentations at industry events including BIO International, Drug Delivery Partnerships, and the Next Generation Pharmaceuticals Summit
•Media interviews with major news outlets including: NPR’s “All Things Considered”, Fox Business News, USA Today, CNN Money, Fortune Magazine, Bloomberg, Forbes, Pharmaceutical Executive, Med Ad News. Author of multiple published articles in Drug Delivery Technology Magazine.
•Nine years in the pharmaceutical industry as a medicinal chemist working on therapeutic/drug area targets including: oncology, metabolic disease/diabetes, interferon, thrombopoietin and the androgen and estrogen receptors (Ligand Pharmaceuticals, San Diego, CA)
•Bachelor of Science in Biochemistry/Economics - Trinity University (San Antonio, TX)
Recent items from Daniel Ruppar
Frost & Sullivan Growth Opportunity Briefings in Asia Pacific (Tokyo, Seoul, Singapore). Covered by the Korean media in Seoul, Korea. Speakers: Daniel Ruppar, Ajay Sunder from Frost & Sullivan giving combined perspectives from our Healthcare and Information/Communication Technologies groups on this important area of cross-industry convergence and h...
|15 Sep 2012||Blog post|
MarketWatch talk Q&A in the Business session track, Speaker: Zachary Bujnoch - Senior Industry Analyst, Connected Health ...
|01 May 2012||Blog post|
Posted the ATA link the other day, but wanted to post this as well along with our pre-event survey link for interested parties.... The telehealth industry can be convoluted and confusing despite significant efforts by the industry. As a result, success in telehealth hinges upon proper understanding and identification of the markets, as well as an...
|19 Apr 2012||Blog post|
Multiple people from our Connected Health group will be at the American Telemedicine Association (ATA) meeting in San Jose, as Frost & Sullivan is a Media partner for this event. We also will be at booth 1703 in the Expo and surveying on trends in telehealth. Hope to see you there. Feel free to contact Daniel Ruppar for scheduled meeting opportunit...
|16 Apr 2012||Blog post|
Is technology changing the doctor-patient relationship? As preventable medical conditions such as obesity continue to grow so does the need for patient involved healthcare. The doctor-patient relationship is critically important to bridging the gap between passive patients and informed medical consumers. Innovative technologies are the enabling...
|09 Apr 2012||Blog post|
There was great attendance and discussion at our event in San Diego around telehealth and mobile health solutions in healthcare. The panel session “mHealth: Are You Ready to Be a Driver of the Future?” featuring executives from Airstrip, Blue Highway, Welldoc, and the Global Hospital Virtualization Program was an exciting one for the conference add...
|06 Apr 2012||Blog post|